NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

July 30, 2025

Conditions

High-grade Squamous Intraepithelial Lesion (HSIL)

Interventions

BIOLOGICAL

NWRD08 administered by electroporation

DNA plasmid delivered via IM injection + electroporation using TERESA device

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Newish Technology (Beijing) Co., Ltd.

INDUSTRY